Vasculitis clinical trials at UCSF

• Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

  open to eligible people ages 18 years and up

  Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

  San Francisco, California

Last updated: February 2020